Blastic NK-Cell Lymphomas (Agranular CD4+CD56+ Hematodermic Neoplasms)
Tony Petrella(Hôpital Maisonneuve-Rosemont), Michael A. Teitell(University of California, Los Angeles), Pierre Déchelotte(Inserm), Martine Bagot(Université Paris Cité), Philippe Bernard(Hôpital Dupuytren), B. Vergier(Centre Hospitalier Universitaire de Bordeaux), S. Dalac(CHU Dijon Bourgogne), L. Machet(Université de Tours), A. De Muret(Centre Hospitalier Universitaire de Tours), P. Joly(Inserm), A. Durlach(Université de Bordeaux), Chris J.L.M. Meijer(Dutch Cancer Society), Florent Grange(Hôpital Lyon Sud), M. Delaunay(Hôpital Larrey), Rein Willemze(Leiden University Medical Center), Philippe Courville(Université de Bordeaux), Janine Wechsler(Hôpitaux Universitaires Henri-Mondor), M. D’Incan(Centre Hospitalier Universitaire de Clermont-Ferrand), M. Beylot‐Barry(Université de Bordeaux), Jacques Bosq(Embody (France)), A. Dompmartin(Centre Hospitalier Universitaire de Caen Normandie)
Cited by 234
Related Papers
Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
|New England Journal of Medicine|2014|2.7k
Prevalence of eating disorders over the 2000–2018 period: a systematic literature review
|American Journal of Clinical Nutrition|2018|1.7k
Overview of the European and North American studies on HPV testing in primary cervical cancer screening
|International Journal of Cancer|2006|1.1k
K-<i>ras</i>Oncogene Activation as a Prognostic Marker in Adenocarcinoma of the Lung
|New England Journal of Medicine|1990|811